Medications

Novartis says EU approves expanded use of Glivec

Swiss pharmaceutical group Novartis said Monday the European Union will allow it to expand its use of the drug Glivec to treat certain rare forms of gastrointestinal cancer.

Oncology & Cancer

EU approves skin cancer fighting drug: Roche

Swiss drug giant Roche said on Monday it had been given European Union approval for its treatment to fight a highly aggressive form of skin cancer.

Genetics

Study tracks mutations causing CDA II back to the Roman Empire

Many of you might know that Congenital Dyserythropoietic Anemia type II (CDA II) is a rare blood disorder, due to a failure in final part of erythropoiesis. What will surprise you is the fact that some mutations responsible ...

Diseases, Conditions, Syndromes

EU offers 2.1 mln euros to research new killer E.coli

The EU is to invest 2.2 million euros in research on the new killer E.coli strain which infected almost 4,000 people and left 51 dead across Europe and caused massive losses to vegetable farmers.

page 31 from 32